Radiofrequency Ablation for Cardiology Market
Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produ ... Read More
Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.
This report contains market size and forecasts of Tumor Radiofrequency Ablation in Global, including the following market information:
Global Tumor Radiofrequency Ablation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tumor Radiofrequency Ablation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lung Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tumor Radiofrequency Ablation include Boston Scientific, Diros Technology, Halyard Health, St. Jude Medical, Cosman Medical, Medtronic, NeuroTherm, Stryker and Cosman Medical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Radiofrequency Ablation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Radiofrequency Ablation Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tumor Radiofrequency Ablation Market Segment Percentages, by Type, 2021 (%)
Lung Cancer
Kidney Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Others
Global Tumor Radiofrequency Ablation Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tumor Radiofrequency Ablation Market Segment Percentages, by Application, 2021 (%)
Hospitals
Cancer Specialty Clinics
Others
Global Tumor Radiofrequency Ablation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tumor Radiofrequency Ablation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Radiofrequency Ablation revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tumor Radiofrequency Ablation revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Diros Technology
Halyard Health
St. Jude Medical
Cosman Medical
Medtronic
NeuroTherm
Stryker
Cosman Medical
Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produ ... Read More
Microwave Ablation Systems is an emerging tissue ablation technique utilized to treat large, smal ... Read More
Microwave Ablation Systems is an emerging tissue ablation technique utilized to treat large, smal ... Read More
Microwave Ablation Systems is an emerging tissue ablation technique utilized to treat large, smal ... Read More